Publication List of the Cerrahpaşa Behçet's Disease Outpatient Clinic



  1. Yazıcı H, Akokan G, Yalçın B, Müftüoğlu A. The high prevalence of HLA B5 in Behçet's disease. Clin Exp Immunol 1977; 30: 259-261.
  2. Yazıcı H. Behçet's disease. Br Med J 1978; 2: 952.
  3. Tüzün Y, Yazıcı H, Pazarlı H, Yalçın B, Yurdakul S, Müftüoğlu A. The usefulness of the nonspecific skin hyperreactivity (The pathergy test) in Behçet's disease in Turkey. Acta Dermatovener (Stockholm) 1979; 59: 77-79.
  4. Yazıcı H, Tüzün Y, Pazarlı H, Yalçın B, Yurdakul S, Müftüoğlu A. The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey. J Rheumatol 1980; 7: 206-210.
  5. Aktulga E, Altaç M, Müftüoğlu A, Özyazgan Y, Pazarlı H, Tüzün Y, Yalçın B, Yazıcı H, Yurdakul S. A double blind study of colchicine in Behçet's disease. Haematologica 1980; 65: 399-402.
  6. Tüzün Y, Altaç M, Yazıcı H, Başöz A, Yurdakul S, Pazarlı H, Yalçın B, Müftüoğlu A. Nonspecific skin hyperreactivity in Behçet's disease. Haematologica 1980; 65: 395-398.
  7. Yazıcı H, Tüzün Y, Pazarlı H, Yurdakul S, Yalçın B, Müftüoğlu A. Behçet's disease as seen in Turkey. Haematologica 1980; 65: 381-383.
  8. Yalçın B, Gürsoy A, Ezer G, Pazarlı H, Tüzün Y, Yurdakul S, Yazıcı H, Müftüoğlu A. Hematological and immunological features of Behçet's disease. Haematologica 1980; 65: 390-394.
  9. Binak K, Uçak D, Yalçın B, Tavşanoğlu S, Aytaç S, Yurdakul S, Müftüoğlu A. Left ventricular aneurysm and acute pericarditis in a case of Behçet's disease. J Rheumatol 1980; 7: 578-580.
  10. Yazıcı H, Chamberlain A, Schreuder I, D'Amano J, Müftüoğlu A. HLA antigens in Behçet's disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis 1980; 39: 344-348.
  11. Yurdakul S, Yazıcı H, Tüzüner N, Aytaç S, Müftüoğlu A. Olecranon nodules in a case of Behçet's disease. Ann Rheum Dis 1981; 40: 182-184.
  12. Yazıcı H, Tüzüner N, Tüzün Y, Yurdakul S. Localized myositis in Behçet's disease. Arthritis Rheum 1981; 24: 636.
  13. Müftüoğlu AÜ, Yazıcı H, Yurdakul S, Pazarlı H, Özyazgan Y, Tüzün Y, Altaç M, Yalçın B. Behçet's disease: lack of correlation of clinical manifestation with antigens. Tissue Antigens 1981; l7: 226-230.
  14. Yazıcı H, Tuzlacı M, Yurdakul S. A controlled survey of sacroiliitis in Behçet's disease. Ann Rheum Dis 1981; 40: 558-559.
  15. Altaç M, Tüzün Y, Yurdakul S, Binyıldız P, Yazıcı H. The validity of the pathergy test (non-specific skin hyperreactivity) in Behçet's disease: A double-blind study by independent observers. Acta Dermatovener (Stockholm) 1982; 62: 158-159.
  16. Yazıcı H, Chamberlain MA, Schreuder I, Bird Stewart J, Denman M. HLA B5 and Behçet's disease. Ann Rheum Dis l983; 42: 602-603.
  17. Yurdakul S, Yazıcı H, Tüzün Y, Pazarlı H, Yalçın B, Altaç M, Özyazgan Y, Tüzüner N, Müftüoğlu A. The arthritis of Behçet's disease: a prospective study. Ann Rheum Dis 1983; 42: 505-515.
  18. Yazıcı H, Chamberlain MA, Tüzün Y, Yurdakul S, Müftüoğlu AÜ. A comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease. Ann Rheum Dis 1984; 43: 74-75.
  19. Yazıcı H, Tüzün Y, Pazarlı H, Yurdakul S, Özyazgan Y, Özdoğan H, Serdaroğlu S, Ersanlı M, Ülkü BY, Müftüoğlu AÜ. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 1984; 43: 783-789.
  20. Dixon JS, Yurdakul S, Surrall KE, Yazıcı H, Chamberlain MA. A study of serum biochemistry in Behçet's syndrome. Br J Rheumatol 1984; 23: 283-287.
  21. Yazıcı H, Tüzün Y, Tanman AB, Yurdakul S, Serdaroğlu S, Pazarlı H, Müftüoğlu A. Male patients with Behçet's syndrome have stronger pathergy reactions. Clin Exp Rheumatol 1985; 3: 137-141.
  22. Müftüoğlu A, Yazıcı H, Yurdakul S, Tüzün Y, Pazarlı H, Güngen G, Deniz Ş. Behçet's disease: Relation of serum C-reactive protein and erythrocyte sedimentation rate to disease activity. Int J Dermatol 1986; 25: 235-239.
  23. Müftüoğlu AÜ, Pazarlı H, Yurdakul S, Yazıcı H, Ülkü BY, Tüzün Y, Serdaroğlu S, Altuğ E, Bahçecioğlu H, Güngen G. Short term cyclosporin A treatment of Behçet's disease. Br J Ophthalmol 1987; 71: 387-390.
  24. Yazıcı H, Hekim N, Özbakır F, Yurdakul S, Tüzün Y, Pazarlı H, Müftüoğlu A. Von Willebrand factor in Behçet's syndrome. J Rheumatol 1987; 14: 305-306.
  25. Yazıcı H, Mat C, Deniz Ş, İşçimen A, Yurdakul S, Tüzün Y, Hekim N, Yazıcı Y. Sebum production is increased in Behçet's syndrome and even more so in rheumatoid arthritis. Clin Exp Rheumatol 1987; 5: 371-374.
  26. Toivanen A, Lahesmaa-Rantala R, Meurman O, Sappinen O, Kosinen T, Yazıcı H, Yurdakul S, Özbakır F, Müftüoğlu A. Antibodies against Yersinia, Campylobacter, Salmonella, and Chlamydia in patients with Behçet's disease. Arthritis Rheum 1987; 30: 1315-1317.
  27. Özbakır F, Yazıcı H, Mat C, Tüzün Y, Yurdakul S, Yılmazer S. HLA antigens in recurrent oral ulceration: evidence against a common disease spectrum with Behçet's syndrome. Clin Exp Rheumatol 1987; 5: 263-265.
  28. Yazıcı H, Turunç M, Özdoğan H, Yurdakul S, Akıncı A, Barnes CG. Observer variation in grading sacroiliac radiographs might be a cause of sacroiliitis reported in certain disease states. Ann Rheum Dis 1987; 46: 139-145.
  29. Yazıcı H. Behçet's syndrome, a personal view. Clin Exp Rheumatol 1987; 5: 1-3 (Editorial).
  30. Yazıcı H. El sindrome de Behçet es una vasculitis o una espondartritis: Rev Esp Rheumatol 1988; 15: 39-41 (Editorial).
  31. Yurdakul S, Günaydın İ, Tüzün Y, Tankurt N, Özyazgan Y, Pazarlı H, Yazıcı H. The prevalence of Behçet's syndrome in a rural area in Northern Turkey. J Rheumatol 1988; 15: 820-822.
  32. Lahesma-Rantala R, Toivanen A, Granfors K, Yurdakul S, Hamuryudan V, Yazıcı H. Anti-yersinia antibodies in patients with Behçet's disease. Arthritis Rheum 1989; 32: 1494-1495.
  33. Serdaroğlu P, Yazıcı H, Özdemir C, Yurdakul S, Bahar S, Aktin E. Neurologic involvement in Behçet's syndrome. Arch Neurol 1989; 46: 265-269.
  34. Oğuz V, Pazarlı H, Özyazgan Y, Yazıcı H, Yurdakul S, Tüzün Y, Serdaroğlu S. Valeur pronostique de l'antigene HLA B5 dans les uveites anterieures isolees de la maladie de Behçet. J Fr Ophtalmol 1989; 12: 431-432.
  35. Hamuryudan V, Yurdakul S, Serdaroğlu S, Tüzün Y, Rosenkaimer F, Yazıcı H. Topical alpha interferon in the treatment of oral ulcers in Behçet's syndrome: a preliminary report. Clin Exp Rheumatol 1990; 8: 51-54.
  36. International study group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-1080.
  37. Yazıcı H, Pazarlı H, Barnes CG, Tüzün Y, Özyazgan Y, Silman A, Serdaroğlu S, Oğuz V, Yurdakul S, Lovatt GE, Yazıcı B, Somani S, Müftüoğlu A. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990 ; 322: 281-285.
  38. Yurdakul S, Tüzüner N, Yurdakul İ, Hamuryudan V, Yazıcı H. Amyloidosis in Behçet's syndrome. Arthritis Rheum 1990; 33: 1586-1589.
  39. Soysal M, Denizci U, Alhan S, Hamuryudan V, Dede H, Yurdakul S, Altuğ A, Yazıcı H. A study of splenic size in Behçet's syndrome. Br J Rheumatol 1990; 29: 497-498.
  40. Hamuryudan V, Yurdakul S, Kural AR, İnce Ü, Yazıcı H. Diffuse proliferative glomerulonephritis in Behçet's syndrome. Br J Rheumatol 1991; 30: 63-64.
  41. Hamuryudan V, Yurdakul S, Rosenkaimer F, Yazıcı H. Inefficacy of topical alpha interferon in the treatment of oral ulcers of Behçet's syndrome: a randomized, double blind trial. Br J Rheumatol 1991: 30; 395-396.
  42. Çakır N, Yazıcı H, Chamberlain MA, Barnes CG, Yurdakul S, Atasoy S, Akçasu A, İşcimen A. Response to intradermal injection of monosodium urate crystals in Behçet's syndrome. Ann Rheum Dis 1991; 50: 634-636.
  43. Hamuryudan V, Yurdakul S, Hekim N, Özbakır F, Yazıcı H. Monozygotic twins concordant for Behçet's sydrome. Arthritis Rheum 1991; 349: 1071-1072.
  44. Yazıcı H, Barnes CG. Practical treatment recommendations for the pharmacotherapy of Behçet's syndrome. Drugs 1991; 42: 796-804.
  45. Özyazgan Y, Yurdakul S, Yazıcı H, Tüzün B, İşcimen A, Tüzün Y, Aktunç T, Pazarlı H, Hamuryudan V, Müftüoğlu A. Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial. Br J Ophthalmol 1992; 76: 241-243.
  46. Özkan M, Emel O, Özdemir M, Yurdakul S, Koçak H, Özdoğan H, Hamuryudan V, Dirican A, Yazıcı H. M-mode, 2-D and Doppler echocardiographic study in 65 patients with Behçet's syndrome. Eur Heart J 1992; 13: 638-641.
  47. Oğuz V, Pazarlı H, Özyazgan Y, Aktunç T, Yazıcı H, Yurdakul S, Müftüoğlu A. L'influence du sexe et de l'age sur l'intensite de l'atteinte oculaire de la maladie de Behçet. Ophthalmologie 1992; 6: 73-75.
  48. Günaydın İ, Yazıcı H, Özbakır F, Hamuryudan V, Yurdakul S. Lymphocytotoxic antibodies in the healty children of patients with Behçet's syndrome. J Rheumatol 1992; 19: 1996-1998.
  49. Yazıcı H. Behçet's Syndrome - The Cerrahpaşa Experience. Sandoz Pharma. Sandorama 1992.
  50. International study group for Behçet's disease. Evaluation of diagnostic (Classification) criteria in Behçet's Disease - Towards internationally agreed criteria. Br J Rheumatol 1992; 31: 299-308.
  51. Oğuz O, Serdaroğlu S, Tüzün Y, Erdoğan N, Yazıcı H, Savaşkan H. Acute febrile neutrophilic dermatosis (Sweet's Syndrome) associated with Behçet's disease. Int J Dermatol 1992; 31: 645-646.
  52. Fresko İ, Yazıcı H, Bayramiçli M, Yurdakul S, Mat C. Effect of surgical cleaning of the skin on the pathergy phenomenon in Behçet's syndrome. Ann Rheum Dis 1993; 52 : 619-620.
  53. Hamuryudan V, Yurdakul S, Moral F, Numan F, Tüzün H, Tüzüner N, Mat C, Tüzün Y, Özyazgan Y, Yazıcı H. Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases. Br J Rheumatol 1994; 33: 48-51.
  54. Hamuryudan V, Moral F, Yurdakul S, Mat C, Tüzün Y, Özyazgan Y, Direskeneli H, Akoğlu T, Yazıcı H. Systemic interferon alpha 2b treatment in Behçet's syndrome. J Rheumatol 1994; 21: 1098-1100.
  55. Günaydın İ, Üstündağ C, Kaner G, Pazarlı H, Yurdakul S, Hamuryudan V, Yazıcı H. The prevalence of Sjögren's sydrome in Behçet's sydrome. J Rheumatol 1994; 21: 1662-1664.
  56. Oğuz V, Pazarlı H, Özyazgan Y, Aslan OS, Yurdakul S, Hamuryudan V, Tüzün Y, Yazıcı H. Les caracteristiques du debut de l'atteinte oculaire dans la maladie de Behçet. Ophthalmologie 1994; 8: 327-329.
  57. Yazıcı H, Yurdakul S, Hamuryudan V. Behçet's syndrome: How should we treat? Clin Immunother 1995; 3: 102-107.
  58. Direskeneli H, Keser G, D'cruz D, Khamashta MA, Akoğlu T, Yazıcı H, Yurdakul S, Hamuryudan V, Özgün Ş, Goral AJ, Hughes GRV. Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease. Clin Rheumatol 1995; 14: 55-61.
  59. Moral F, Hamuryudan V, Yurdakul S, Yazıcı H. Inefficacy of azapropazone in the acute arthritis of Behçet's syndrome: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol 1995; 13: 493-495.
  60. Hamuryudan V, Sonsuz A, Yurdakul S. More on Hepatitis C virus and Behçet's syndrome. N Eng J Med 1995; 333: 322.
  61. Jorizzo JL, Abernethy JL, White WL, Mangelsdorf HC, Zouboulis CC, Sarıca R, Gaffney K, Mat CM, Yazıcı H, Al Ialaan A, Assad Khalil, Kaneko F, Jorizzo F. Mucocutaneous criteria for diagnosis Behçet's disease: An analysis of clinicopathologic data from multiple international centers. J Am Acad Dermatol 1995; 32: 968-976.
  62. Yurdakul S, Tüzüner N, Yurdakul İ, Hamuryudan V, Yazıcı H. Gastrointestinal involvement in Behçet's syndrome: a controlled study. Ann Rheum Dis 1996; 55: 208-210.
  63. Yazıcı H, Başaran G, Hamuryudan V, Hızlı N, Yurdakul S, Mat C, Tüzün Y, Özyazgan Y, Dimitriyadis İ. The ten-year mortality in Behçet's syndrome. Br J Rheumatol 1996; 35: 139-141.
  64. Tüzün H, Hamuryudan V, Yıldırım S, Beşirli K, Yörük Y, Yurdakul S, Yazıcı H. Surgical therapy of pulmonary arterial aneurysms in Behçet's syndrome. Ann Thorac Surg 1996; 61: 733-735.
  65. Akman-Demir G, Baykan-Kurt B, Serdaroğlu P, Gürvit H, Yurdakul S, Yazıcı H, Bahar S, Aktin E. Seven-year follow-up of neurologic involvement in Behçet's syndrome. Arch Neurol 1996; 53: 691-694.
  66. Çoban O, Bahar S, Akman-Demir G, Serdaroğlu P, Baykan-Kurt B, Tolun R, Yurdakul S, Yazıcı H. A controlled study of relieability and validity of MR findings in neuro-Behçet's disease. Neuroradiol 1996; 38: 312-316.
  67. Tüzün Y, Yurdakul S, Mat MC, Özyazgan Y, Hamuryudan V, Tüzün B, Yazıcı H. Epidemiology of Behçet's syndrome. Int J Dermatol 1996; 35: 618-620.
  68. Yurdakul S, Tüzüner N, Yurdakul İ, Hamuryudan V, Yazıcı H. Gastrointestinal involvement Behçet's syndrome: a controlled study. Ann Rheum Dis 1996; 55: 208-210.
  69. Şahin Özgün Ş, Lawrence R, Direskeneli H, Hamuryudan V, Yazıcı H, Akoğlu T. Monocyte activity in Behçet's disease. Br J Rheumatol 1996; 35: 424-429.
  70. Hamuryudan V, Yurdakul S, Yazıcı H. Morbus Behçet. Rheumatology in Europe 1997; 26: 31-33.
  71. Hamuryudan V, Özyazgan Y, Hızlı N, Mat MC, Yurdakul S, Tüzün Y, Şenocak M, Yazıcı H. Azatioprin in Behçet's syndrome. Arthritis Rheum 1997; 40: 769-774.
  72. Tüzün H, Beşirli K, Sayın A, Vural FS, Hamuryudan V, Hızlı N, Yurdakul S, Yazıcı H. Management of aneurysms in Behçet's syndrome: An analysis of 24 patients. Surgery 1997; 121: 150-156.
  73. Mat CM, Nazarbaghi M, Tüzün Y, Hamuryudan V, Hızlı N, Yurdakul S, Baykal E, Özyazgan Y, Yazıcı H. Wound healing in Behçet's syndrome. Int J Dermatol 1998;37: 120-123.

Main Page